Yongfeng Hui

804 Shengli South Street
Yinchuan, 750004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

PROK1 Induces Macrophage M2 Phenotype Conversion to Promote Pancreatic Cancer Progression by Activating the PI3K/AKT Pathway Via Interacting with PROKR2.

PROK1 Induces Macrophage M2 Phenotype Conversion to Promote Pancreatic Cancer Progression by Activating the PI3K/AKT Pathway Via Interacting with PROKR2.

Journal: Applied biochemistry and biotechnology

Published: May 29, 2026

Single-cell and spatial transcriptomics reveal correlation between RNA methylation-related miRNA risk model and immune infiltration in hepatocellular carcinoma.

Single-cell and spatial transcriptomics reveal correlation between RNA methylation-related miRNA risk model and immune infiltration in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: December 30, 2024

TMCO1 regulates energy metabolism and mitochondrial function of hepatocellular carcinoma cells through TOMM20, affecting the growth of subcutaneous graft tumors and infiltration of CAFs.

TMCO1 regulates energy metabolism and mitochondrial function of hepatocellular carcinoma cells through TOMM20, affecting the growth of subcutaneous graft tumors and infiltration of CAFs.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: November 20, 2024

CXCR7 promoted proliferation, migration and invasion in HCC Cells by inactivating Hippo-YAP signaling.

CXCR7 promoted proliferation, migration and invasion in HCC Cells by inactivating Hippo-YAP signaling.

Journal: Discover oncology

Published: September 09, 2024

FOXO1 enhances G6PD expression to promote cancer cell antioxidative capacity.

FOXO1 enhances G6PD expression to promote cancer cell antioxidative capacity.

Journal: Journal of molecular cell biology

Published: August 15, 2024

BRG1 promotes liver cancer cell proliferation and metastasis by enhancing mitochondrial function and ATP5A1 synthesis through TOMM40.

BRG1 promotes liver cancer cell proliferation and metastasis by enhancing mitochondrial function and ATP5A1 synthesis through TOMM40.

Journal: Cancer biology & therapy

Published: July 09, 2024

Knockdown of long noncoding RNA AL161431.1 inhibits malignant progression of cholangiocarcinoma.

Knockdown of long noncoding RNA AL161431.1 inhibits malignant progression of cholangiocarcinoma.

Journal: Aging

Published: November 15, 2023

LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3/SLC7A11 in hepatocellular carcinoma.

LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3/SLC7A11 in hepatocellular carcinoma.

Journal: Functional & integrative genomics

Published: July 10, 2023

PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer.

PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer.

Journal: Open life sciences

Published: April 21, 2022

A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma.

A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma.

Journal: Disease markers

Published: August 23, 2021

18F-FDG PET/CT in a Patient With Malignant Pheochromocytoma Recurrence and Bone Metastasis After Operation-Case Report and Review of the Literature.

18F-FDG PET/CT in a Patient With Malignant Pheochromocytoma Recurrence and Bone Metastasis After Operation-Case Report and Review of the Literature.

Journal: Frontiers in medicine

Published: June 30, 2021

Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway.

Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway.

Journal: Pathology, research and practice

Published: June 18, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026